Targeting MCL-1 protein to treat cancer: opportunities and challenges
Article in Frontiers in Oncology (July 2023)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas
Article in Leukemia & Lymphoma (April 2023)
Discovery of Mcl-1 inhibitors through virtual screening, molecular dynamics simulations and in vitro experiments
Article in Computers in Biology and Medicine (November 2022)